News
- Author:
- Victoria Stern
Publish date: March 4, 2025
US Food and Drug Administration approved 2 new medications and changed indications for 2 more.
News
- Author:
- Victoria Stern
Publish date: November 22, 2024
The increase likely reflects previously undetected cases instead of a true rise in new cases, say the authors of new research.
News
- Author:
- Victoria Stern
Publish date: September 27, 2024
Researchers explored toxicity and 90-day mortality outcomes in patients who received SBRT.
News
- Author:
- Victoria Stern
Publish date: August 21, 2024
FDA declines to approve linvoseltamab for treatment of relapsed/refractory multiple myeloma, citing issues at a third-party manufacturer.
News
- Author:
- Victoria Stern
Publish date: July 8, 2024
Researchers investigate whether converting free-text radiology reports into structured reports can benefit surgeons.
News
- Author:
- Victoria Stern
Publish date: January 5, 2024
The major issue overall is the disconnect between the time spent waiting for prior authorization approvals and the necessity of many treatments.
News
- Author:
- Victoria Stern
Publish date: December 8, 2023
These expensive “milestone treatments” greenlighted by the FDA are the first gene-based therapies for sickle cell disease.
News
- Author:
- Victoria Stern
Publish date: February 17, 2023
The patient was experiencing severe side effects from standard chemoradiation with weekly cisplatin.
News
- Author:
- Victoria Stern
Publish date: January 23, 2023
Exasperated doctor takes insurance coverage dispute to Twitter.
News
- Author:
- Victoria Stern
Publish date: July 28, 2022
“It’s part of the discomfort you live with as a patient and oncologist, and when I leave the clinic, that’s one thing that follows me home.”
News
- Author:
- Victoria Stern
Publish date: June 1, 2022
Last February, the FDA said it was investigating a possible increased risk of death associated with umbralisib. Five months later, the results are ...
News
- Author:
- Victoria Stern
Publish date: February 28, 2022
“There are fewer facilities in rural areas, so residents need to travel longer distances to reach a facility.”
News
- Author:
- Victoria Stern
Publish date: February 4, 2022
Clinical trial findings of “possible increased risk of death” associated with the drug umbralisib for CLL prompted the FDA to announce reevaluation...
Article
- Author:
- Victoria Stern
Publish date: April 8, 2021
New antibody-drug conjugates are a step in the right direction, but the key to developing effective therapies hin...
